Implicaciones genéticas y de la biología molecular en el tratamiento quirúrgico del cáncer gástrico
Resumen
Palabras clave
Referencias
International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence worldwide in 2018[Internet]. Ginebra:International Agency for Research on Cancer;2018[citado 10 May 2020]. Disponible en: https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf.
Slavin TP, Weitzel JN, Neuhausen SL, Schrader KA, Oliveira C, Karam R. Genetics of gastric cancer: what do we know about the genetic risks? Transl Gastroenterol Hepatol. 2019;4(1):55.
Aguirre RE, Serra MA, Aguirre ME. Visión holística de nuevos desafíos: paradigmas tecnológicos y fundamentos bioéticos en la Medicina futurista. Rev haban cienc méd[Internet]. 2017[citado 15 Ago 2019];16(5):[aprox. 10p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2017000500016&lng=es.
Machlowska J, Maciejewski R, Sitarz R. The Pattern of Signatures in Gastric Cancer Prognosis. Int J Mol Sci. 2018;19(6):1658.
Ferreira M, Ferreira H, Rey JA, Pinto GR, Cardoso M, Moreira CA, et al. YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process. Oncotarget. 2016;7(51):85393-410.
Amigo JD, Opazo JC, Jorquera R, Wichmann IA, García BA, Alarcon MA, et al. The Reprimo Gene Family: A Novel Gene Lineage in Gastric Cancer with Tumor Suppressive Properties. Int J Mol Sci. 2018;19(7):1862.
Chintalacheruvu LM, Shaw T, Buddam A, Diab O, Kassim T, Mukherjee S, et al. Major hereditary gastrointestinal cancer syndromes: a narrative review. J Gastrointest Liver Dis. 2017;26(2):157-63.
Jansen AML, Goel A. Mosaicism in Patients With Colorectal Cancer or Polyposis Syndromes: A Systematic Review. Clin Gastroenterol Hepatol. 2020;18(9):1949-60.
Bhattacharya P, McHugh TW. Lynch Syndrome[Internet]. Treasure Island:StatPearls;2020[citado 2 Feb 2021]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28613748/.
Lv XP. Gastrointestinal tract cancers: Genetics, heritability and germ line mutations. Oncol Lett. 2017;13(3):1499-1508.
Spoto CPE, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Semin Diagn Pathol. 2018;35(3):170-83.
Rudloff U. Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives. Clin Exp Gastroenterol. 2018;11(1):447-59.
Lérias JR, Paraschoudi G, Silva I, Martins J, de Sousa E, Condeço C, et al. Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine. Int J Mol Sci. 2019;20(8):1986.
Bagno A, Martini R. Bridging the gap between basic research on microcirculation and clinical world: The translational marriage between engineering and medicine. Clin Hemorheol Microcirc. 2019;71(3):357-63.
Deans C, Maggert KA. What do you mean, “Epigenetic”? Genetics. 2015;199(4):887-96.
Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol. 2018;24(26):2818-32.
Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202-9.
Tian SB, Yu JC, Kang WM, Ma ZQ, Ye X, Cao ZJ, et al. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Asian Pac J Cancer Prev. 2014;15(15):6295-300.
Virgilio E, Proietti A, D'Urso R, Cardelli P, Giarnieri E, Montagnini M, et al. Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability. Anticancer Res. 2017;37(6):2817-21.
Li F, Li S, Wei L, Liang X, Zhang H, Liu J. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Biomarkers. 2013;18(7):632-7.
Kotzev AI, Draganov PV. Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing? Gastrointest Tumors 2018;5(1-2):1-13.
Porta C, Paglino C, Mosca A. Targeting PI3K/Akt/mTOR Signaling in Cancer. Front Oncol. 2014;4(1):64.
Lizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses. 2012;4(12):3420-39.
Matsumoto K, Umitsu M, De Silva DM, Roy A, Bottaro DP. Hepatocyte growth factor/MET in cancer progression and biomarker discovery. Cancer Sci. 2017;108(3):296-307.
Panarese I, De Vita F, Ronchi A, Romano M, Alfano R, Di Martino N, et al. Predictive biomarkers along gastric cancer pathogenetic pathways. Expert Rev Anticancer Ther. 2017;17(5):417-25.
Committee of the Korean Gastric Cancer Association. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer. 2019;19(1):1-48.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1-21.
Skill N, Maluccio M. Contemporary paradigm for the evaluation and treatment of hereditary gastric cancer. Transl Gastroenterol Hepatol. 2019;4(1):14.
Enlaces refback
- No hay ningún enlace refback.
FINLAY EN:
FINLAY CERTIFICADA POR:
Esta revista "no aplica" cargos por publicación en ninguna etapa del proceso editorial.
Dirección postal: Calle 51A y Avenida 5 de Septiembre Cienfuegos, Cuba Código postal: 55100.
http://www.revfinlay.sld.cu
Telefono: +53 43 516602. Telefax: +53 43 517733.
amgiraldoni@infomed.sld.cu
ISSN: 2221-2434
RNPS: 5129